Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Return on Equity: 2017-2018

Historic Return on Equity for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2018 value amounting to -0.69%.

  • Astria Therapeutics' Return on Equity rose 131.00% to -0.69% in Q4 2018 from the same period last year, while for Dec 2018 it was -0.69%, marking a year-over-year increase of 131.00%. This contributed to the annual value of -1.11% for FY2018, which is N/A change from last year.
  • Per Astria Therapeutics' latest filing, its Return on Equity stood at -0.69% for Q4 2018, which was down 16.05% from -0.59% recorded in Q3 2018.
  • Astria Therapeutics' Return on Equity's 5-year high stood at -0.59% during Q3 2018, with a 5-year trough of -2.20% in Q1 2018.
  • Its 2-year average for Return on Equity is -1.28%, with a median of -0.91% in 2018.
  • Data for Astria Therapeutics' Return on Equity shows a peak YoY spiked of 131bps (in 2018) over the last 5 years.
  • Over the past 2 years, Astria Therapeutics' Return on Equity (Quarterly) stood at -2.00% in 2017, then spiked by 131bps to -0.69% in 2018.
  • Its Return on Equity was -0.69% in Q4 2018, compared to -0.59% in Q3 2018 and -0.91% in Q2 2018.